Long-term Outcome of TNF Alpha Therapy in IBD
NCT04575701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 538
Last updated 2021-02-25
Summary
The aim of this retrospective study is to assess the outcome of patients with inflammatory bowel disease (IBD) under TNF-alpha antibody therapy over a period of 20 years
Conditions
Interventions
- OTHER
-
TNF Alpha therapy
Retrospective analysis of outcome of first TNF Alpha therapy
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Wolfgang Petritsch, Prof · Meduni Graz
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2020-06-01
- Completion
- 2020-07-01
Countries
- Austria
Study Locations
More Related Trials
-
Predictors of Prognosis in IBD Patients
NCT05653011 ·Status: RECRUITING
-
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
NCT04646187 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972 ·Status: NOT_YET_RECRUITING
-
Long-term Functional Outcome of Children With Inflammatory Bowel Disease
NCT02152241 ·Status: COMPLETED
-
Inflammatory Bowel Disease in South Eastern Norway
NCT02727959 ·Status: COMPLETED
-
Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF
NCT01605188 ·Status: COMPLETED
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
NCT02322008 ·Status: COMPLETED
-
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
NCT06015789 ·Status: COMPLETED
-
Endoscopic Remission, Histologic Remission and Barrier Healing for Predicting Disease Behaviour in IBD
NCT05157750 ·Status: UNKNOWN
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD
NCT06214299 ·Status: NOT_YET_RECRUITING
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease
NCT04761952 ·Status: UNKNOWN ·Phase: NA
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311 ·Status: RECRUITING
-
Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases
NCT03134508 ·Status: COMPLETED
-
Multi-omics to Predict Responses to Biologics in IBD
NCT05542459 ·Status: UNKNOWN
-
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.
NCT05986903 ·Status: UNKNOWN
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Improving the Health Care in Inflammatory Bowel Disease.
NCT02770599 ·Status: UNKNOWN
-
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525 ·Status: RECRUITING
-
Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study
NCT06802887 ·Status: RECRUITING